Development Of A Prototype Production System For Optical Fibre Diagnostic Probes
Funder
National Health and Medical Research Council
Funding Amount
$191,598.00
Summary
Advances in nanotechnology have led to new techniques for the precise fabrication of nanometre scale structures. A recent breakthrough by the applicants now allows high-quality nanostructures to be stamped onto the tip of low-cost optical fibre probes. When coated with silver, these sensitive probes can be used for continuous monitoring of blood glucose in diabetics and in critical care situations. This project aims to develop a prototype manufacturing system for optical fibre glucose probes.
Spectrometer Module For Surface Enhanced Raman Scattering Spectroscopy In Glucose Analysis
Funder
National Health and Medical Research Council
Funding Amount
$385,151.00
Summary
Scientists have developed a number of incredibly powerful and sophisticated techniques to identify chemicals and measure their concentrations in the laboratory. However, it remains a major challenge to perform these measurements under everyday circumstances. For example, surface-enhanced Raman scattering (SERS) has gained widespread recognition as a technique for trace chemical detection, but it remains confined to a small number of specialist laboratories. For this reason, Dr Paul Stoddart at S ....Scientists have developed a number of incredibly powerful and sophisticated techniques to identify chemicals and measure their concentrations in the laboratory. However, it remains a major challenge to perform these measurements under everyday circumstances. For example, surface-enhanced Raman scattering (SERS) has gained widespread recognition as a technique for trace chemical detection, but it remains confined to a small number of specialist laboratories. For this reason, Dr Paul Stoddart at Swinburne University of Technology recognised a need for more practical SERS probes for field applications. His team has now developed a proprietary SERS probe, based on an optical fibre that is little thicker than a hair. These optical fibres can form the core element of field-portable SERS spectrometers. This work has recently been boosted by the discovery in the United States that SERS can be used to monitor glucose in blood. The development of a continuous glucose monitor has long been a holy grail of sensor research, because of the millions of diabetes sufferers who regularly perform the painful finger prick test. For SERS to provide a practical solution to glucose monitoring, it is recognised that SERS optical fibres are needed for minimally invasive probes. With support from Biopharmica and the Diabetes Australia Research Trust, Dr Stoddart's team has now demonstrated that sensitive SERS probes can be produced in large quantities. The next objective is to develop a prototype low-cost SERS spectrometer for use as part of a continuous glucose monitoring system. This will require the development of a laser source and spectroscopic system that can interface to the SERS probes. It is proposed to use an Australian designed and manufactured laser system based on a low-power narrow-linewidth laser diode. The project plans to bring together Swinburne University, OptoTech and Grey Innovation in order to develop a commercially scaleable and robust device.Read moreRead less
Type 2 diabetes causes significant health problems. The fundamental reasons underlying this disease are not fully known and will require molecular analysis of proteins critical to blood glucose control. This work aims to define a novel pathway that responds to circulating nutrients. The research will enhance our understanding of the links between diet and metabolic disease, with potential to reveal much needed therapeutic targets and/or dietary interventions for the treatment of Type 2 diabetes.
Glucose, Glucose Transporters And Blastocyst Formation In The Mouse
Funder
National Health and Medical Research Council
Funding Amount
$281,650.00
Summary
Embryo-based biotechnologies have the potential to improve human reproductive health, notably in treating infertility by In vitro fertilisation (IVF). They are also central to the future use of embryonic stem cells for human tissue replacement. This project investigates the molecular mechanisms controlling one of the earliest differentiations in the growth of the embryo. Using the mouse as an experimental model it will investigate the importance of several factors in the changes which set up the ....Embryo-based biotechnologies have the potential to improve human reproductive health, notably in treating infertility by In vitro fertilisation (IVF). They are also central to the future use of embryonic stem cells for human tissue replacement. This project investigates the molecular mechanisms controlling one of the earliest differentiations in the growth of the embryo. Using the mouse as an experimental model it will investigate the importance of several factors in the changes which set up the placenta and fetus as seperate tissues in the very early embryo. A key focus is the supply of glucose to the newly fertilised embryo and how important this glucose supply is for the survival of the embryo. Moreover there is great interest in the possibility that metabolic events in utero can contribute to the development of diseases in later life, notably, coronary heart diease, stroke, high blood pressure and non-insulin dependent diabetes. The results from these studies will contribute to our understanding of why some couples are infertile, lead to improved management of infertility by diet and invitro fertilisation procedures. It will also be of benefit in dietary advice to women with diabetes mellitus, seeking to have children. The adenoviral strategy for gene delivery into early mouse embryos may in the long term also find wide clinical application in the treatment of genetic defects at the very earliest stages in development and as such is of enormous potential benefit in the management of both animal and human reproduction.Read moreRead less